FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Potassium Acetate Injection
Status: Currently in Shortage
»Date first posted: 06/10/2019
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Exela Pharma Sciences, LLC (Revised 05/16/2022)

Company Contact Information:
828-758-5474

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Potassium Acetate Inj. 40mEq (2mEq/ml) 20mL (NDC 51754-2001-4) Product shipped to and available in wholesalers. Additional shipment end of May 2022. Increased supply available in mid-June. Check with your local wholesaler or contact Exela on our website at www.exelapharma.com to order direct. Demand increase for the drug

Hospira, Inc. (Revised 05/12/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3294-51) Next Delivery: June 2022; Estimated Recovery: August 2022

Pfizer Customer Letter Dates May 10, 2022

Other
40 mEq/20 mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 00409-8183-01) Next Delivery and Estimated Recovery: June 2022

Pfizer Customer Letter Dates May 10, 2022

Other
100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3294-25), Novaplus Next Delivery: September 2022; Estimated Recovery: October 2022 Other
40 mEq/20 mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 0409-8183-25), Novaplus Next Delivery and Estimated Recovery: June 2022 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English